Page 2 - E Wesley Ely News Today

Share this article Share this article INDIANAPOLIS, April 8, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ:INCY) announced today results of COV-BARRIER, a Phase 3 study evaluating baricitinib 4 mg once daily plus standard of care (SoC) versus placebo plus SoC. The trial did not meet statistical significance on the primary endpoint, which was defined as a difference in the proportion of participants progressing to the first occurrence of non-invasive ventilation incl...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. BioXcel Therapeutics to Host Virtual Key Opinion Leader Event to Highlight BXCL501 as a ... BioXcel TherapeuticsFebruary 12, 2021 GMT NEW HAVEN, Conn., Feb. 12, 2021 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (“BioXcel” or the “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscienc...

Because of Unnecessary Sedation and Intubation? Tue Dec 22, 2020 There will at some point be a reckoning, if only historical, for the horrifying mishandling of the pandemic, not by President Trump, as the media insists, but by the experts. The push to secure hospitals managed to wreck the finances of many medical facilities, force infected patients into nursing homes resulting in massive deaths in long term care facilities, alongside this medieval mistreatment of hospitalized coronavir...

Hospitals Retreat From Early Covid Treatment and Return to Basics AP Photo Melanie Evans , The Wall Street Journal Changing practices, based on data and experience, appear to be improving outcomes for the sickest coronavirus patients Share Via Read Full Story Doctors are treating a new flood of critically ill coronavirus patients with treatments from before the pandemic, to keep more patients alive and send them home sooner. Last spring, with less known about the disease, doctors often pre-em...